Beyond lines of treatment: embracing early high-efficacy disease-modifying treatments for multiple sclerosis management

Oreja‐Guevara, Celia; Martínez‐Yélamos, Sergio; Eichau, Sara; Llaneza, M.; Martín-Martínez, Jesús; Peña-Martínez, Joaquín; Meca‐Lallana, Virginia; Alonso, Ana; Moral‐Torres, Ester; Río, Jordi; Calles, Carmen; Arés-Luque, Adrián; Ramió‐Torrentà, Lluís; Eugenia Marzo-Sola, María; M. Prieto, José; Luisa Martínez‐Ginés, María; Arroyo, Rafael; Ángeles Otano-Martínez, María; Brieva, Luís; Gómez-Gutiérrez, Montserrat; Rodríguez Antigüedad, Alfredo; Galán Sánchez-Seco, Victoria; Costa‐Frossard, Lucienne; Ángel Hernández Pérez, Miguel; Landete-Pascual, Lamberto; González-Platas, Montserrat; Meca-Lallana, José

doi:10.1177/17562864241284372

Public

Beyond lines of treatment: embracing early high-efficacy disease-modifying treatments for multiple sclerosis management

Published in Therapeutic Advances in Neurological Disorders • Jan 1, 2024

Authors:

Celia Oreja‐Guevara

Sergio Martínez‐Yélamos

Sara Eichau

Abstract

Recent advances in multiple sclerosis (MS) management have shifted perspectives on treatment strategies, advocating for the early initiation of high-efficacy disease-modifying therapies (heDMTs). This perspective review discusses the rationale, benefits, and challenges associated with early heDMT in...

Subject

Medicine

Intensive care medicine

Adverse effect

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!